Imaging Endpoints Celebrates Tenth Consecutive Year of High Growth and Contribution
Imaging Endpoints is perhaps the fastest-growing imaging CRO (iCRO) in the industry. We are proud to celebrate our tenth consecutive year of impressive growth and contribution to our mission of Connecting Imaging to the CureTM. Client retention and leadership in imaging science, technology and compliance have enabled Imaging Endpoints to emerge as one of the largest global iCROs.
Imaging Endpoints is a recognized leader in complex trials and partners with sponsors to navigate both early-phase trials and global late-stage trials, providing real-time reads for real-time decisions. As new, more effective technologies for disease detection and treatment have rapidly emerged, the demand for leadership in imaging science has also rapidly grown.
Clinical trial imaging is increasingly a complex science that may be a differentiator in drug development success. Imaging Endpoints’ leadership in providing the best in imaging science backed by customized, highly-compliant services has enabled it to develop a strong partnership with small and large pharmaceutical, biotechnology and medical device companies globally.
